Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To demonstrate non-inferiority of CJ-12420 to lansoprazole 30 mg capsule in terms of therapeutic efficacy, and to confirm safety of CJ-12420, after once daily oral administration of CJ-12420 50 mg, 100 mg or Lansoprazole 30 mg capsule in gastric ulcer patients.
Epistemonikos ID: d691cce5c1629d7ac5a1fa77ed2a9f7085a258f9
First added on: May 13, 2024